BTG Pactual hires Charles Rosier for European business
Charles Rosier’s Job
The French-speaking markets of France, Belgium and Quebec were handled by charles rosier (www.efinancialnews.com/story/2010-09-17/charles-rosier-joins-btg) when he worked at UBS Warburg. Having 30 years of experience in working with international markets, BTG Pactual currently employs 2,500 personnel. In 1999, Goldman Sachs (GMS) offered him a new job opportunity. He accepted the offer and joined as their Managing Director. Charles Rosier finally joined BTG Pactual in August 2010. BTG Pactual, an investment bank in Latin America, is a company at which Charles Rosier became a partner.
Charles Rosier’s Health Related Projects
Charles Rosier was the primary investor of the successful project, for which a drug was being tested to cure stroke that causes damage to the spinal cord. He invested in a pharmaceutical organisation (Mapreg) to build a healthcare project, handled by Professor Etienne Baulieu. He funded Mapreg, a laboratory based in Paris, in order to do a study regarding stroke, depression and other serious diseases. Being an investor, Charles Rosier receives a profit-share from the company because of his contribution that enabled the company to begin doing the study.
Charles Rosier financed MPOWERD to formulate other energy solutions such as lanterns. With this, MPOWERD delivered these solutions to more than 25 poor nations around the planet. To provide energy solutions to poor countries, MPOWERD established economical LED lanterns. Innoveox is a French company working with the objective of establishing a friendly and pollution-free environment... with Charles Rosier being its partner.
A Brief Glimpse at Charles Rosier’s Life Story
His interests include extreme sports, environmental activities, culture and studies. Charles Rosier studied at Fenelon Sainte-Marie and earned his scientific degree in 1991. Charles Rosier took two years of additional classes at a famous private school named Integrale, where he studied for ESCP Europe.